News
Search here results
search-total-matching109search-total-matching- Advances in treatment for adult leukaemia highlighted by national trial results | UCL Cancer Institute - UCL – University College London
- Bone cancer patients could benefit from novel therapy using existing drugs | UCL Cancer Institute - UCL – University College London
- Edward Showler Foundation and UCL partner to accelerate research into clear cell sarcoma | UCL Cancer Institute - UCL – University College London
- Professor Mark Emberton awarded OBE in Queen’s Birthday Honours | UCL Faculty of Medical Sciences - UCL – University College London
- Combination immunotherapy for metastatic prostate cancer shows promise | UCL Cancer Institute - UCL – University College London
- Cells from the centre of tumours most likely to spread around the body | UCL Cancer Institute - UCL – University College London
- From lab to clinic: Redefining CD25 as an immunotherapy drug target | UCL Cancer Institute - UCL – University College London
- Research into childhood cancers awarded innovation funding | UCL Cancer Institute - UCL – University College London
- Cancer in a time of COVID – keeping vital research and treatment on track | UCL Cancer Institute - UCL – University College London
- Genetic changes in tumours could help predict if patients will respond to immunotherapy | UCL Cancer Institute - UCL – University College London
Please enable JavaScript to use this page or visit this page for a non javascript version.